Intracoronary Pharmacotherapy (Verapamil-Epinephrine-Adenosine) for Prevention of No Reflow during Primary Percutaneous Coronary Intervention in Patients with ST Elevation Myocar - Egyptian Knowledge Bank

326334

Intracoronary Pharmacotherapy (Verapamil-Epinephrine-Adenosine) for Prevention of No Reflow during Primary Percutaneous Coronary Intervention in Patients with ST Elevation Myocar

Article

Last updated: 05 Jan 2025

Overview Similar Items

Article

Role of Intracoronary Adenosine on Prevention of No Reflow during Primary PCI in STEMI Patients Guided by MVO in CMR

Article

Role of intracoronary adenosine on prevention of no reflow during Primary PCI in STEMI patients guided by MVO in CMR

Article

Efficacy of Distal Intracoronary Epinephrine and Glycoprotein IIb/IIIa Inhibitors in the Treatment of No-reflow during Percutaneous

Article

IMPACT OF INTRACORONARY ADENOSINE ADMINISTRATION DURING PRIMARY PERCUTANEOUS CORONARY INTERVENTION

Article

Impact of Intracoronary Adenosine Administration During Primary PCI

Article

Primary ‎Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction

Article

Myocardial Preconditioning by Intracoronary Adenosine before Elective Percutaneous Coronary Intervention (short term outcome)

Article

Understanding the No-Reflow Phenomenon in Coronary Interventions: A Comprehensive Review

Article

Predictors of No-Reflow Phenomenon after Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients

Article

EFFECT OF LOCAL DELIVERY OF STREPTOKINASE BEFORE PRIMARY PERCUTANEOUS CORONARY INTERVENTION ON MICROVASCULAR PERFUSION IN ACUTE MYOCARDIAL INFARCTION PATIENTS